Group One Trading
TTNP

Group One Trading’s Titan Pharmaceuticals TTNP Stock Holding History

Group One Trading’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5
Closed -$47 – 8217
2023
Q3 		$47 Hold
5
– – ﹤0.01% 7506
2023
Q2 		$65 Buy
+5
New +$76 ﹤0.01% 7533
2022
Q1 		– Sell
-150
Closed -$3K – 8741
2021
Q4 		$3K Sell
150
-235
-61% -$7.08K ﹤0.01% 7816
2021
Q3 		$14K Buy
385
+200
+108% +$8.76K ﹤0.01% 7362
2021
Q2 		$10K Sell
185
-250
-57% -$12.5K ﹤0.01% 7537
2021
Q1 		$26K Buy
+435
New +$28.8K ﹤0.01% 6642
2020
Q4 		– Sell
-271
Closed -$27K – 7015
2020
Q3 		$27K Hold
271
– – ﹤0.01% 4996
2020
Q2 		$50K Buy
+271
New +$46.7K ﹤0.01% 4363
2017
Q2 		– Sell
-21
Closed -$248K – 5103
2017
Q1 		$248K Sell
21
-16
-43% -$225K ﹤0.01% 2373
2016
Q4 		$538K Buy
37
+5
+16% +$84.2K 0.01% 1721
2016
Q3 		$674K Sell
32
-3
-9% -$58.3K 0.01% 1585
2016
Q2 		$688K Sell
35
-2
-5% -$42.6K 0.01% 1502
2016
Q1 		$637K Buy
37
+36
+3,600% +$480K 0.01% 1509
2015
Q4 		$8K Buy
+1
New +$16.3K ﹤0.01% 4260

Other funds holding TTNP

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Group One Trading's TTNP Position: Q4 2025 in Review

Group One Trading sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 12 shares — an estimated $58 sold.

Group One Trading first reported a position in TTNP in Q4 2019 and held it in 23 quarters. The position peaked at $218K in Q1 2021. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.

  • Group One Trading reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 12 Titan Pharmaceuticals shares in Q4 2025, an estimated $58.
  • Group One Trading first reported a position in Titan Pharmaceuticals in Q4 2019 and held it in 23 quarters.
  • Group One Trading's Titan Pharmaceuticals position peaked at $218K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.